{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:23:46Z","timestamp":1774617826831,"version":"3.50.1"},"reference-count":33,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T00:00:00Z","timestamp":1688428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Aim and Objectives: The objective of our retrospective study was to investigate the changes in pNFH levels in cerebrospinal fluid, which is a reliable marker of neuronal damage, after the loading dose of nusinersen in different types of spinal muscular atrophy. Materials and Methods: We analyzed the spinal muscular atrophy types, the number of copies of the SMN2 gene, and the progression of the motor status using specific motor function scales in a group of 38 patients with spinal muscular atrophy types 1, 2, and 3. Results: We found a significant inverse correlation between pNFH levels and patient age, progress on functional motor scales, and nusinersen administration. Our results also revealed that the neurofilament levels in the cerebrospinal fluid were higher in patients with 2 SMN2 copies than those with more than 2 copies, although the association was not statistically significant due to the abnormal distribution of the values. Conclusions: We identified several predictors of favorable evolution under nusinersen treatment, including spinal muscular atrophy type 1, children aged \u2264 30 months, and the presence of only 2 copies of SMN2. Our study provides important insights into the use of pNFH as a biomarker to monitor disease progression and responses to treatment in patients with spinal muscular atrophy.<\/jats:p>","DOI":"10.3390\/medicina59071244","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:33:42Z","timestamp":1688517222000},"page":"1244","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Changes in pNFH Levels in Cerebrospinal Fluid and Motor Evolution after the Loading Dose with Nusinersen in Different Types of Spinal Muscular Atrophy"],"prefix":"10.3390","volume":"59","author":[{"given":"Mihaela","family":"Badina","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of Medicine and Pharmacy \u201cCarol Davila\u201d, 37 Dionisie Lupu Street, 020021 Bucharest, Romania"},{"name":"National Teaching Center for Children\u2019s Neurorehabilitation \u201cDr. Nicolae Robanescu\u201d, 44 Dumitru Minca Street, 041408 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1859-5877","authenticated-orcid":false,"given":"Gabriel Cristian","family":"Bejan","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, University of Medicine and Pharmacy \u201cCarol Davila\u201d, 8 Eroii Sanitari Bvd., 050474 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3481-9690","authenticated-orcid":false,"given":"Corina","family":"Sporea","sequence":"additional","affiliation":[{"name":"National Teaching Center for Children\u2019s Neurorehabilitation \u201cDr. Nicolae Robanescu\u201d, 44 Dumitru Minca Street, 041408 Bucharest, Romania"},{"name":"Faculty of Midwifery and Nursing, University of Medicine and Pharmacy \u201cCarol Davila\u201d, 37 Dionisie Lupu Street, 020021 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana","family":"Padure","sequence":"additional","affiliation":[{"name":"National Teaching Center for Children\u2019s Neurorehabilitation \u201cDr. Nicolae Robanescu\u201d, 44 Dumitru Minca Street, 041408 Bucharest, Romania"},{"name":"Faculty of Midwifery and Nursing, University of Medicine and Pharmacy \u201cCarol Davila\u201d, 37 Dionisie Lupu Street, 020021 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrada","family":"Mirea","sequence":"additional","affiliation":[{"name":"National Teaching Center for Children\u2019s Neurorehabilitation \u201cDr. Nicolae Robanescu\u201d, 44 Dumitru Minca Street, 041408 Bucharest, Romania"},{"name":"Faculty of Midwifery and Nursing, University of Medicine and Pharmacy \u201cCarol Davila\u201d, 37 Dionisie Lupu Street, 020021 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madalina-Cristina","family":"Leanca","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Medicine and Pharmacy \u201cCarol Davila\u201d, 37 Dionisie Lupu Street, 020021 Bucharest, Romania"},{"name":"National Teaching Center for Children\u2019s Neurorehabilitation \u201cDr. Nicolae Robanescu\u201d, 44 Dumitru Minca Street, 041408 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihaela","family":"Axente","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Medicine and Pharmacy \u201cCarol Davila\u201d, 37 Dionisie Lupu Street, 020021 Bucharest, Romania"},{"name":"National Teaching Center for Children\u2019s Neurorehabilitation \u201cDr. Nicolae Robanescu\u201d, 44 Dumitru Minca Street, 041408 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florin Petru","family":"Grigoras","sequence":"additional","affiliation":[{"name":"National Teaching Center for Children\u2019s Neurorehabilitation \u201cDr. Nicolae Robanescu\u201d, 44 Dumitru Minca Street, 041408 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihaela","family":"Bejan","sequence":"additional","affiliation":[{"name":"National Teaching Center for Children\u2019s Neurorehabilitation \u201cDr. Nicolae Robanescu\u201d, 44 Dumitru Minca Street, 041408 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4658-2416","authenticated-orcid":false,"given":"Elena-Silvia","family":"Shelby","sequence":"additional","affiliation":[{"name":"National Teaching Center for Children\u2019s Neurorehabilitation \u201cDr. Nicolae Robanescu\u201d, 44 Dumitru Minca Street, 041408 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Neagu","sequence":"additional","affiliation":[{"name":"National Teaching Center for Children\u2019s Neurorehabilitation \u201cDr. Nicolae Robanescu\u201d, 44 Dumitru Minca Street, 041408 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela Adriana","family":"Ion","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, National Institute for Infectious Diseases Prof. Dr. Matei Bals, University of Medicine and Pharmacy \u201cCarol Davila\u201d, 1 Calistrat Grozovici Street, 021105 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"FNL6","DOI":"10.2217\/fnl-2018-0029","article-title":"Cerebrospinal fluid biomarkers in neurodegenerative disorders","volume":"14","author":"Robey","year":"2019","journal-title":"Futur. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1242\/jcs.104729","article-title":"Neurofilaments at a glance","volume":"125","author":"Yuan","year":"2012","journal-title":"J. Cell Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e22948","DOI":"10.1002\/jcla.22948","article-title":"Neurofilament levels in patients with neurological diseases: A comparison of neurofilament light and heavy chain levels","volume":"33","author":"Zeman","year":"2019","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jns.2005.03.015","article-title":"Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss","volume":"233","author":"Petzold","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"ref_5","first-page":"620","article-title":"Neurofilament proteins in axonal regeneration and neuro-degenerative diseases","volume":"7","author":"Wang","year":"2012","journal-title":"Neural Regen. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000099473","article-title":"CSF Neurofilaments in Frontotemporal Dementia Compared with Early Onset Alzheimer\u2019s Disease and Controls","volume":"23","author":"Pijnenburg","year":"2007","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"a018309","DOI":"10.1101\/cshperspect.a018309","article-title":"Neurofilaments and Neurofilament Proteins in Health and Disease","volume":"9","author":"Yuan","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fmolb.2016.00007","article-title":"Copy Number Variations in the Survival Motor Neuron Genes: Implications for Spinal Muscular Atrophy and Other Neurodegenerative Diseases","volume":"3","author":"Butchbach","year":"2016","journal-title":"Front. Mol. Biosci."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Li, W. (2017). How do SMA-linked mutations of SMN1 lead to structural\/functional deficiency of the SMA protein?. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0178519"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Hua, Y., Vickers, T.A., Baker, B.F., Bennett, C.F., and Krainer, A.R. (2007). Enhancement of SMN2 exon 7 inclusion by antisense oligonu-cleotides targeting the exon. PLoS Biol., 5.","DOI":"10.1371\/journal.pbio.0050073"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.nmd.2008.05.008","article-title":"Survival in SMA type I: A prospective analysis of 34 consecutive cases","volume":"18","author":"Cobben","year":"2008","journal-title":"Neuromuscul. Disord."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"760-e163","DOI":"10.1111\/j.1468-1331.2009.02595.x","article-title":"EFNS guidelines on disease-specific CSF investigations","volume":"16","author":"Deisenhammer","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.nmd.2015.04.009","article-title":"209th ENMC international workshop: Outcome measures and clinical trial readiness in spinal muscular atrophy 7\u20139 November 2014, Heemskerk, The Netherlands","volume":"25","author":"Finkel","year":"2015","journal-title":"Neuromuscul. Disord."},{"key":"ref_14","unstructured":"Biogen (2022, December 10). Measures of Mobility and Physical Ability Evaluated in Clinical Trials n.d. Available online: https:\/\/www.spinrazahcp.com\/content\/dam\/commercial\/spinraza\/hcp\/en_us\/pdf\/mobility-and-physical-ability.pdf."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1756285618754459","DOI":"10.1177\/1756285618754459","article-title":"Nusinersen for spinal muscular atrophy","volume":"11","author":"Wurster","year":"2018","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"ref_16","unstructured":"Ciulu-Costinescu, F. (2017). Raport de Evaluare a Tehnologiilor Medicale DCI: Elosulfase Alfa Indica\u021bia: Mucopolizaharidoza tip IVA, Agentia Nationala a Medicamentului si a Dispozitivelor Medicale."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/1060028018789956","article-title":"Nusinersen: A Treatment for Spinal Muscular Atrophy","volume":"53","author":"Claborn","year":"2018","journal-title":"Ann. Pharmacother."},{"key":"ref_18","unstructured":"Boiten, W. (2003). Hydrometry: IHE Delft Lecture Note Series, CRC Press."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1080\/00031305.1990.10475751","article-title":"A suggestion for using powerful and informative tests of normality","volume":"44","author":"Belanger","year":"1990","journal-title":"Am. Stat."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"MacFarland, T.W., Yates, J.M., MacFarland, T.W., and Yates, J.M. (2016). Introduction to Nonparametric Statistics for the Biological Sciences Using R, Springer.","DOI":"10.1007\/978-3-319-30634-6"},{"key":"ref_21","first-page":"13","article-title":"On a use of the Mann-Whitney statistic","volume":"Volume 1","author":"Birnbaum","year":"1956","journal-title":"Proceedings of the Third Berkeley Symposium on Mathematical Statistics and Probability"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Pallant, J. (2020). SPSS Survival Manual: A Step by Step Guide to Data Analysis Using IBM SPSS, Routledge.","DOI":"10.4324\/9781003117452"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4097\/kjae.2015.68.6.540","article-title":"T test as a parametric statistic","volume":"68","author":"Kim","year":"2015","journal-title":"Korean J. Anesthesiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/beheco\/ark016","article-title":"The unequal variance t-test is an underused alternative to Student\u2019s t-test and the Mann\u2013Whitney U test","volume":"17","author":"Ruxton","year":"2006","journal-title":"Behav. Ecol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1213\/ANE.0b013e31827f53d7","article-title":"A Review of Analysis and Sample Size Calculation Considerations for Wilcoxon Tests","volume":"117","author":"Divine","year":"2013","journal-title":"Anesth. Analg."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/sim.4780040112","article-title":"A wilcoxon-type test for trend","volume":"4","author":"Cuzick","year":"1985","journal-title":"Stat. Med."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Myers, L., and Sirois, M.J. (2004). Spearman correlation coefficients, differences between. Encycl. Stat. Sci., 12.","DOI":"10.1002\/0471667196.ess5050"},{"key":"ref_28","unstructured":"Armitage, P., Berry, G., and Matthews, J.N.S. (2008). Statistical Methods in Medical Research, John Wiley & Sons."},{"key":"ref_29","unstructured":"Lehmann, E.L., Romano, J.P., and Casella, G. (2005). Testing Statistical Hypotheses, Springer."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/acn3.779","article-title":"Neurofilament as a potential biomarker for spinal muscular atrophy","volume":"6","author":"Darras","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_32","unstructured":"Darras, B.T., Sumner, C.J., Muntoni, F., Crawford, T.O., Finkel, R.S., Mercuri, E., De Vivo, D.C., Oskoui, M., Tizzano, E.F., and Ryan, M.M. (2020). Plasma Phosphorylated Neurofilament Heavy Chain Levels Over Time in Participants with Infantile-and Later-onset SMA: Data from the SHINE Study (1692). Neurology, 94, Available online: https:\/\/n.neurology.org\/content\/94\/15_Supplement\/1692."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/acn3.51625","article-title":"Biochemical and clinical biomarkers in adult SMA 3\u20134 patients treated with nusinersen for 22 months","volume":"9","author":"Poesen","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/7\/1244\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:05:50Z","timestamp":1760126750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/7\/1244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,4]]},"references-count":33,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["medicina59071244"],"URL":"https:\/\/doi.org\/10.3390\/medicina59071244","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,4]]}}}